下載本文檔
版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemECA-074 methyl esterCat. No.: HY-100350CAS No.: 147859-80-1Synonyms: CA-074Me分式: CHNO分量: 397.47作靶點(diǎn): Cathepsin作通路: Metabolic Enzyme/Protease儲(chǔ)存式: Powder -20C 3 yearsIn solvent -80C 6 months-20C 1 month溶解性數(shù)據(jù)體外實(shí)驗(yàn) DMSO : 215 mg/mL (54
2、0.92 mM)H2O : 26.66 mg/mL (67.07 mM; Need warming)* means soluble, but saturation unknown.Mass Solvent1 mg 5 mg 10 mg Concentration制備儲(chǔ)備液1 mM 2.5159 mL 12.5796 mL 25.1591 mL5 mM 0.5032 mL 2.5159 mL 5.0318 mL10 mM 0.2516 mL 1.2580 mL 2.5159 mL請(qǐng)根據(jù)產(chǎn)品在不同溶劑中的溶解度,選擇合適的溶劑配制儲(chǔ)備液,并請(qǐng)注意儲(chǔ)備液的保存式和期限。BIOLOGICAL ACTI
3、VITY物活性 CA-074 methyl ester種特異性的 Cathepsin B 抑制劑,具有保護(hù)神經(jīng),抗癌、抗炎等多種物活性。體外研究CA-074Me (5 M and 50 M) inhibits RANKL-induced osteoclastogenesis in BMM cells derived fromC57BL/6J and NOD/ShiLtJ mice. CA-074Me exerts its anti-osteoclastogenic effect within 24 hours post-RANKL stimulation in vitro. CA-074Me
4、does not exert its anti-osteoclastogenic effect via the MAPK-ERK1/3 Master of Small Molecules 您邊的抑制劑師www.MedChemEsignaling cascade. CA-074Me inhibits c-FOS upregulation and subsequent NFATc1 autoamplificationfollowing RANKL stimulation. 2. CA-074Me reduces apoptosis induced by CVB1 3.體內(nèi)研究 Hippocampa
5、l CA1 neuronal programmed necrosis induced by global cerebral I/R injury is prevented byCA074-me (1 g, 10 g) both pre-treatment and post-treatment. The rupture of lysosomal membrane and theleakage of cathepsin-B, and this is strongly inhibited by CA074-me pre-treatment. The overexpression andnuclear
6、 translocation of RIP3 and the reduction of NAD+ level after I/R injury are also inhibited, while theupregulation of Hsp70 is strengthened by CA074-me pre-treatment 1. CA-074Me (30 mg/kg) is capable ofinhibiting osteoclastogenesis and bone degradation in vivo 2. In the CVB+CA-074Me (4 mg/kg/day i.m.
7、)guinea pigs group, the scores of inflammation significantly decrease in comparison with the CVB+Nonegroup. In CVB+CA-074Me group, the number of CD8+T cells decrease in comparison with the sham group3.PROTOCOLKinase Assay 2 After seven days of cell culture and osteoclast generation, the media is rem
8、oved and washed three timeswith PBS. BMMs are fixed with a fixing solution supplied by the manufacturer. The cells are incubated at37C with a solution containing deionized water, Fast Garnet GBC, Napthol phosphate, Acetate, and Tartratefor 1 h. The staining solution is removed, washed with PBS (3),
9、and air-dried. TRAP positive cells with threeor more nuclei across whole culture area are counted as multinucleated osteoclasts using light microscopy.MCE has not independently confirmed the accuracy of these methods. They are for reference only.Animal RANKL (0.08 mg/kg) with and without CA-074Me (1
10、0 mg/kg or 30 mg/kg) are mixed in sterile,Administration 2 nonimmunogenic 1% Extracel-HP gel. The gel is composed of thiol-modified sodium hyaluronate, thiol-modified heparin, thiol-modified gelatin, and degassed deionized sterile water. The hydrogel mixture isprepared in an aseptic hood using a ste
11、rile syringe. The control sham hydrogel contained sterile PhosphateBuffered Saline (PBS) without any cytokines. The osteolysis group is given 0.08 mg/kg RANKL in a hydrogelto induce pathologic bone loss. The hydrogel-only, hydrogel-RANKL, and hydrogel-RANKL-CA-074Memixture is injected into 8-week ol
12、d male mice calvarium in an aseptic hood (n = 5) following generalanesthesia (80 mg/kg of ketamine and 7 mg/kg of xylazine). After four days, the calvaria are excised, fixed in4% formaldehyde for 24 h, decalcified in 20% EDTA for one week, and sectioned into slides from paraffinblocks. The slides un
13、dergo Tartrate-Resistant Acid Phosphatase (TRAP) staining to identify osteoclasts.MCE has not independently confirmed the accuracy of these methods. They are for reference only.戶使本產(chǎn)品發(fā)表的科研獻(xiàn) Cell Mol Immunol. 2019 Jul 18. Environ Sci Technol. 2017 Dec 5;51(23):13938-13948. Toxicol Appl Pharmacol. 2018
14、 Oct 1;356:159-171. Biosci Rep. 2019 Jun 20.See more customer validations on HYPERLINK / www.MedChemE2/3 Master of Small Molecules 您邊的抑制劑師www.MedChemEREFERENCES1. Xu Y, et al. Protective mechanisms of CA074-me (other than cathepsin-B inhibition) against programmed necrosis induced by globalcerebral
15、ischemia/reperfusion injury in rats. Brain Res Bull. 2016 Jan;120:97-105.2. Patel N, et al. CA-074Me compound inhibits osteoclastogenesis via suppression of the NFATc1 and c-FOS signaling pathways. J OrthopRes. 2015 Oct;33(10):1474-86.3. Zhang L, et al. Treatment with CA-074Me, a Cathepsin B inhibitor, reduces lung interstitial inflammation and fibrosis in a rat model ofpolymyositis. Lab
溫馨提示
- 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- 山東聊城大學(xué)招聘考試試卷及答案
- 瀘州市龍馬潭區(qū)事業(yè)單位招聘工作人員考試試卷及答案
- 元宵節(jié)的日記集合5篇
- 元宵節(jié)日記模板四篇
- 軍訓(xùn)心得體會(huì)
- 賽迪前瞻2024年第26期(總866期):人工智能中小企業(yè)發(fā)展成效顯著但仍面臨三大隱憂 - 水印版
- 2020年山東濱州中考滿分作文《青春是暖陽(yáng)》
- 2020年江蘇宿遷中考滿分作文《日子普通也精彩》
- 漁業(yè)機(jī)械智能制造的數(shù)據(jù)分析與應(yīng)用考核試卷
- 錫冶煉行業(yè)綠色發(fā)展模式與案例考核試卷
- 電網(wǎng)運(yùn)行安全校核技術(shù)規(guī)范
- 汽車坡道玻璃雨棚施工方案
- 人教鄂教版五年級(jí)上冊(cè)科學(xué)全冊(cè)教案
- 24春國(guó)家開放大學(xué)《兒童心理學(xué)》形考任務(wù)1-5參考答案
- 質(zhì)量管理監(jiān)督檢查記錄表
- 福建省福州市2023-2024學(xué)年七年級(jí)上學(xué)期期中數(shù)學(xué)試題
- 污水處理廠污泥處理處置污泥運(yùn)輸處置方案
- 關(guān)于小學(xué)數(shù)學(xué)課堂中數(shù)形結(jié)合教學(xué)的調(diào)查研究的開題報(bào)告
- 黃磷生產(chǎn)安全培訓(xùn)課件模板
- 關(guān)于PCB IC上錫不良分析報(bào)告
- 2024年科技部事業(yè)單位招聘95人歷年高頻考題難、易錯(cuò)點(diǎn)模擬試題(共500題)附帶答案詳解
評(píng)論
0/150
提交評(píng)論